tm logo
Trademark Search
THE LIFE CYCLE MANAGEMENT COMPANY

View On IC.GC.CA

THE LIFE CYCLE MANAGEMENT COMPANY
OPPOSED

on 15 Nov 2024

Last Applicant/ Owned by

Atnahs Pharma UK Limited

Sovereign House, Miles Gray Road, BasildonEssex SS14 3FR

GB

Serial Number

2176301 filed on 28th Jan 2022

Correspondent Address

560 boul. Crémazie Est3e étageMontréal

QUEBEC

CA

H2P1E8

THE LIFE CYCLE MANAGEMENT COMPANY

Trademark usage description

pharmaceutical products and preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids); p Read More

Classification Information

Class [005]
Pharmaceutical products and preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical products and preparations for the treatment of metabolic diseases and disorders, namely, diabetes, gout, arthritis and anemia, of endocrine diseases, namely, glucagonoma; Pharmaceutical products and preparations for the treatment of musculoskeletal disorders and diseases; Pharmaceutical products and preparations for the treatment of cardiovascular disorders and diseases, of cardiopulmonary disorders and diseases; Pharmaceutical products and preparations for the treatment of genitourinary diseases, namely, infertility, urological diseases, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical products and preparations for the treatment of oncological disorders and diseases; Pharmaceutical products and preparations for the treatment of hepatological disorders and diseases; Pharmaceutical products and preparations for the treatment of ophthalmic disorders and diseases; Pharmaceutical products and preparations for the treatment of respiratory disorders and diseases; Pharmaceutical products and preparations for the treatment of neurological disorders and diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical products and preparations for the treatment of gastrointestinal disorders and diseases; Pharmaceutical products and preparations for the treatment of hormonal disorders and diseases; Pharmaceutical products and preparations for the treatment of dermatological diseases, namely, viral skin infections, parasitic skin infections, acne, psoriasis, eczema, dermatitis, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata; Pharmaceutical products and preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical products and preparations for the treatment of autoimmune diseases and disorders; pharmaceutical products and preparations, namely, antivirals, analgesic, antipyretic and anti-inflammatory products and preparations; pharmaceutical products and preparations for the prevention and treatment of ocular disorders and diseases, bacteria-based diseases, namely, intestinal bacteria and parasites diseases, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; pharmaceutical products and preparations for the prevention and treatment of cancer;

Classification kind code

11

Class [035]
Retail and wholesale services connected with the sale of pharmaceutical products and preparations.

Classification kind code

11

Mark Details

Serial Number

2176301

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 13th Jul 2023		Search Recorded
Submitted for opposition 20
on 13th Jul 2023		Examiner's First Report
Submitted for opposition 223
on 13th Jul 2023		Total Provisional Refusal
Submitted for opposition 135
on 13th Apr 2023		Amendment to Application
Submitted for opposition 256
on 31st Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 31st Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 30th Mar 2022		Formalized
Submitted for opposition 1
on 30th Mar 2022		Created
Submitted for opposition 228
on 28th Jan 2022		International Registration
Submitted for opposition 30
on 28th Jan 2022		Filed